ESR1 and breast carcinoma: We recently demonstrated that PBX1 is a pioneer factor in ERα-positive breast cancer, occupying the chromatin prior to ERα binding following its activation with estrogen and regulating the expression of estrogen dependent genes associated with aggressive progression [16].